Award
National Cancer Institute 5R01CA218501-06
Neurocognitive Changes from Long-Term Androgen Deprivation Therapy in Prostate Cancer Patients
Recipient
Yale University
Award Amount
$323,336.00
Ceiling
$323,336.00
Awarded
July 28, 2023
Identifier
5R01CA218501-06
Award for research on cognitive impairment in prostate cancer patients receiving androgen deprivation therapy, involving neurocognitive testing and brain imaging to identify cognitive deficits and predictive cerebral markers.
Description
This project aims to examine the neural processes of cognitive impairment in prostate cancer patients undergoing androgen deprivation therapy (ADT). It involves neurocognitive testing, clinical assessments, and brain imaging to identify cognitive deficits and their impact on quality of life. The study also seeks to identify cerebral markers that may predict cognitive impairment, with a focus on early detection and management.